Breaking News Instant updates and real-time market news.

CLBS

Caladrius

$4.17

0.02 (0.48%)

07:36
11/22/16
11/22
07:36
11/22/16
07:36

Caladrius subsidiary earns FACT re-accreditation

Caladrius Biosciences announced that PCT, its cell therapy contract development and manufacturing subsidiary, has earned re-accreditation by the Foundation for the Accreditation of Cellular Therapy, or FACT. This accreditation confirms that PCT operates in compliance with the FACT-JACIE International Standards for Cellular Therapy Product Collection, Processing and Administration at both its Allendale, New Jersey and Mountain View, California sites.

CLBS Caladrius
$4.17

0.02 (0.48%)

01/07/16
01/07/16
DOWNGRADE

On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: 1st Constitution Bancorp (FCCY) downgraded to Market Perform at Raymond James... Alaska Air (ALK) downgraded to Neutral from Outperform at Credit Suisse... Alexion (ALXN) downgraded to Neutral from Buy at BTIG... Anadarko (APC) downgraded to Hold from Buy at Deutsche Bank... Apple Hospitality REIT (APLE) downgraded to Neutral from Outperform at Baird... Aqua America (WTR) downgraded to Neutral from Buy at Ladenburg... ArcBest (ARCB) downgraded to Equal Weight from Overweight at Stephens... Ashford Hospitality Prime (AHP) downgraded to Underperform from Neutral at Baird... Broadcom (BRCM) downgraded to Market Perform from Outperform at Bernstein... Brown & Brown (BRO) downgraded to Neutral from Buy at SunTrust... Caladrius (CLBS) downgraded to Hold from Buy at Maxim... Capital One (COF) downgraded to Hold from Buy at Deutsche Bank... DDR Corp. (DDR) downgraded to Neutral from Outperform at Baird... Everyday Health (EVDY) downgraded on salesforce issues at Stifel... Expeditors (EXPD) downgraded to Sell from Neutral at UBS... First Community (FCCO) downgraded to Market Perform from Outperform at Raymond James... Genesee & Wyoming (GWR) downgraded to Sector Perform from Outperform at RBC Capital... HP Inc. (HPQ) downgraded to Market Perform from Outperform at Wells Fargo... Heartland Express (HTLD) downgraded to Underperform from Sector Perform at RBC Capital... Highwoods Properties (HIW) downgraded to Neutral from Outperform at Baird... Horizon Bancorp (HBNC) downgraded to Hold from Buy at Sandler O'Neill... Hubbell (HUBB) downgraded to Neutral from Overweight at JPMorgan... Illumina (ILMN) downgraded to Market Perform from Outperform at Wells Fargo... Kite Realty Trust (KRG) downgraded to Neutral from Outperform at Baird... Mondelez (MDLZ) downgraded to Hold from Buy at Deutsche Bank... Moody's (MCO) downgraded to Neutral from Overweight at Piper Jaffray... Morgan Stanley says Nordstrom (JWN) not immune from industry headwinds, cuts to sell... National Retail Properties (NNN) downgraded to Market Perform from Outperform at Raymond James... Navios Maritime (NM) downgraded to Sell on cash burn at Stifel... Newmont Mining (NEM) downgraded to Sector Perform from Outperform at RBC Capital... Nordstrom (JWN) downgraded to Underweight from Equal Weight at Morgan Stanley... Old Dominion (ODFL) downgraded to Sector Perform from Outperform at RBC Capital... Paychex (PAYX) downgraded to Underperform from Neutral at BofA/Merrill... PerkinElmer (PKI) downgraded to Market Perform from Outperform at Cowen... Piedmont Office Realty (PDM) downgraded to Neutral from Outperform at Baird... Post Properties (PPS) downgraded to Market Perform from Outperform at Raymond James... Public Storage (PSA) downgraded to Market Perform from Outperform at Raymond James... Rush Enterprises (RUSHA) downgraded to Sector Perform from Outperform at RBC Capital... Ryder (R) downgraded to Sector Perform from Outperform at RBC Capital... Saia, Inc. (SAIA) downgraded to Equal Weight from Overweight at Stephens... Scorpio Bulkers (SALT) downgraded to Hold from Buy at Stifel... Spirit Realty (SRC) downgraded to Neutral from Outperform at Baird... Star Bulk Carriers (SBLK) downgraded to Hold from Buy at Stifel... Stryker (SYK) downgraded to Market Perform from Outperform at Northland... Swift Transport (SWFT) downgraded to Sector Perform from Outperform at RBC Capital... Team (TISI) downgraded to Hold from Buy at BB&T... Terreno Realty (TRNO) downgraded to Neutral from Outperform at Baird... Thomson Reuters (TRI) downgraded to Neutral from Buy at BofA/Merrill... UBS (UBS) downgraded to Equal Weight from Overweight at Barclays... WebMD (WBMD) downgraded to Hold from Buy at Stifel... Whiting USA Trust II (WHZ) downgraded to Underperform at Raymond James... Zimmer Biomet (ZBH) downgraded to Market Perform from Outperform at Northland.
01/08/16
HCWC
01/08/16
DOWNGRADE
HCWC
Neutral
Caladrius downgraded to Neutral from Buy at H.C. Wainwright
H.C. Wainwright analyst Yi Chen downgraded Caladrius Biosciences to Neutral saying the company has no ongoing trial with proof-of-concept data after deciding to discontinue the Phase 3 study of CLBS20 as a monotherapy for metastatic melanoma.
01/08/16
01/08/16
DOWNGRADE

On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: A.O. Smith (AOS) downgraded to Hold from Buy at Maxim... Aetna (AET) downgraded to Hold from Buy at Jefferies... Air France-KLM (AFLYY) downgraded to Sell from Neutral at UBS... BHP Billiton (BHP) downgraded to Neutral from Outperform at Macquarie... Barracuda (CUDA) downgraded to Sector Weight from Overweight at Pacific Crest... Boston Beer (SAM) downgraded to Hold from Buy at Jefferies... Caladrius (CLBS) downgraded to Neutral from Buy at H.C. Wainwright... Canadian Natural (CNQ) downgraded to Neutral from Outperform at Macquarie... Cliffs Natural (CLF) downgraded to Neutral from Outperform at Macquarie... Community Health (CYH) downgraded to Neutral from Outperform at Wedbush... Container Store (TCS) downgraded to Neutral from Overweight at JPMorgan... D.R. Horton (DHI) downgraded to Market Perform from Outperform at Raymond James... Energizer (ENR) downgraded to Hold from Buy at Jefferies... Enerplus (ERF) downgraded to Neutral from Outperform at Macquarie... Finisar (FNSR) downgraded to Equal Weight from Overweight at Barclays... Freeport McMoRan (FCX) downgraded to Neutral from Outperform at Macquarie... Globus Medical (GMED) downgraded to Underperform from Buy at BofA/Merrill... Hollysys (HOLI) downgraded to Neutral from Outperform at Credit Suisse... International Paper (IP) downgraded to Equal Weight from Overweight at Barclays... InvenSense (INVN) downgraded to Neutral from Buy at Rosenblatt... KB Home (KBH) downgraded to Neutral from Buy at MKM Partners... Keysight Technologies (KEYS) downgraded to Neutral from Outperform at Baird... Lumentum (LITE) downgraded to Underweight from Equal Weight at Barclays... Mattress Firm (MFRM) downgraded to Neutral from Buy at UBS... Mead Johnson (MJN) downgraded to Underperform from Outperform at CLSA... Media General (MEG) downgraded to Hold from Buy at Gabelli... Mosaic (MOS) downgraded to Market Perform from Outperform at BMO Capital... Quidel (QDEL) downgraded to Market Perform from Outperform at William Blair... United Technologies (UTX) downgraded to Market Perform from Outperform at Bernstein... Veritiv (VRTV) downgraded to Underweight from Overweight at Barclays... Volvo (VOLVY) downgraded to Underweight from Neutral at JPMorgan... WestRock (WRK) downgraded to Equal Weight from Overweight at Barclays... Williams-Sonoma (WSM) downgraded to Neutral from Buy at Buckingham.
04/29/16
HCWC
04/29/16
UPGRADE
Target $1.25
HCWC
Buy
Caladrius upgraded to Buy from Neutral at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju upgraded Caladrius Biosciences to Buy with a $1.25 price target citing the company's collaboration agreement with Hitachi Chemical.

TODAY'S FREE FLY STORIES

GPP

Green Plains Partners

$17.85

-0.15 (-0.83%)

07:06
12/06/16
12/06
07:06
12/06/16
07:06
Upgrade
Green Plains Partners rating change  »

Green Plains Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$25.82

-0.07 (-0.27%)

07:05
12/06/16
12/06
07:05
12/06/16
07:05
Hot Stocks
AstraZeneca says data presented shows TAGRISSO superiority over chemotherapy »

AstraZeneca presented…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 16

    Feb

EARS

Auris Medical

07:05
12/06/16
12/06
07:05
12/06/16
07:05
Hot Stocks
Auris Medical on track to resume enrollment of Keyzilen Phase 3 trial »

Auris Medical Holding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNCR

Synchronoss

$49.00

1.81 (3.84%)

, IL

Intralinks

$11.27

0.11 (0.99%)

07:04
12/06/16
12/06
07:04
12/06/16
07:04
Earnings
Synchronoss sees FY17 pro forma EPS $2.45-$2.60 for combined entity »

May not compare to…

SNCR

Synchronoss

$49.00

1.81 (3.84%)

IL

Intralinks

$11.27

0.11 (0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 12

    Dec

  • 13

    Dec

CHTR

Charter

$270.93

4.26 (1.60%)

07:04
12/06/16
12/06
07:04
12/06/16
07:04
Initiation
Charter initiated  »

Charter initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

MDGN

Medgenics

07:04
12/06/16
12/06
07:04
12/06/16
07:04
Initiation
Medgenics initiated  »

Medgenics initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

AM

Antero Midstream

$28.48

-0.1 (-0.35%)

07:04
12/06/16
12/06
07:04
12/06/16
07:04
Upgrade
Antero Midstream rating change  »

Antero Midstream upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSBC

HSBC

$39.86

0.17 (0.43%)

07:03
12/06/16
12/06
07:03
12/06/16
07:03
Upgrade
HSBC rating change  »

HSBC upgraded to Equal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGTX

TG Therapeutics

$5.70

0.2 (3.64%)

07:03
12/06/16
12/06
07:03
12/06/16
07:03
Hot Stocks
TG Therapeutics GENUINE Phase 3 study reaches target enrollment »

TG Therapeutics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNCR

Synchronoss

$49.00

1.81 (3.84%)

07:03
12/06/16
12/06
07:03
12/06/16
07:03
Hot Stocks
Synchronoss to divest part of activation business to Sequential for $146M »

Synchronoss is also…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

SNCR

Synchronoss

$49.00

1.81 (3.84%)

, IL

Intralinks

$11.27

0.11 (0.99%)

07:03
12/06/16
12/06
07:03
12/06/16
07:03
Hot Stocks
Synchronoss to acquire Intralinks for $13/share, or $821M in equity value »

Synchronoss Technologies…

SNCR

Synchronoss

$49.00

1.81 (3.84%)

IL

Intralinks

$11.27

0.11 (0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 12

    Dec

  • 13

    Dec

TEVA

Teva

$37.04

0.51 (1.40%)

07:02
12/06/16
12/06
07:02
12/06/16
07:02
Recommendations
Teva analyst commentary  »

Wells views departure of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Apr

NVCN

Neovasc

$1.42

0.56 (65.12%)

07:02
12/06/16
12/06
07:02
12/06/16
07:02
Hot Stocks
Neovasc provides update on Tiara transcatheter mitral valve »

Neovasc provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDS

GDS Holdings

$9.93

-0.07 (-0.70%)

07:02
12/06/16
12/06
07:02
12/06/16
07:02
Initiation
GDS Holdings initiated  »

GDS Holdings initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNCR

Synchronoss

$49.00

1.81 (3.84%)

, IL

Intralinks

$11.27

0.11 (0.99%)

07:02
12/06/16
12/06
07:02
12/06/16
07:02
Hot Stocks
Breaking Hot Stocks news story on Synchronoss, Intralinks »

Synchronoss to acquire…

SNCR

Synchronoss

$49.00

1.81 (3.84%)

IL

Intralinks

$11.27

0.11 (0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 12

    Dec

  • 13

    Dec

KKR

KKR

$15.67

0.19 (1.23%)

, BX

Blackstone

$26.40

0.54 (2.09%)

07:01
12/06/16
12/06
07:01
12/06/16
07:01
Hot Stocks
KKR to acquire Optiv Security from investors, including fund managed by Blackstone »

Optiv Security, a…

KKR

KKR

$15.67

0.19 (1.23%)

BX

Blackstone

$26.40

0.54 (2.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

  • 12

    Dec

  • 13

    Dec

AZO

AutoZone

$776.42

-7.32 (-0.93%)

07:00
12/06/16
12/06
07:00
12/06/16
07:00
Earnings
AutoZone reports Q1 EPS $9.36, consensus $9.31 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 14

    Dec

ROP

Roper Technologies

$181.64

-0.68 (-0.37%)

, PROJ

Deltek

06:59
12/06/16
12/06
06:59
12/06/16
06:59
Hot Stocks
Roper Technologies to buy Deltek in all cash transaction valued at $2.8B »

Roper Technologies (ROP)…

ROP

Roper Technologies

$181.64

-0.68 (-0.37%)

PROJ

Deltek

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$228.55

5.19 (2.32%)

06:59
12/06/16
12/06
06:59
12/06/16
06:59
Periodicals
Goldman Sachs leads financing round in Canadian startup Hubba, WSJ says »

Goldman Sachs led a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

ROP

Roper Technologies

$181.64

-0.68 (-0.37%)

, PROJ

Deltek

06:57
12/06/16
12/06
06:57
12/06/16
06:57
Hot Stocks
Breaking Hot Stocks news story on Roper Technologies, Deltek »

Roper Technologies to buy…

ROP

Roper Technologies

$181.64

-0.68 (-0.37%)

PROJ

Deltek

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBB

Cincinnati Bell

$21.05

0.7 (3.44%)

06:56
12/06/16
12/06
06:56
12/06/16
06:56
Downgrade
Cincinnati Bell rating change  »

Cincinnati Bell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

BCS

Barclays

$10.97

0.27 (2.52%)

, DB

Deutsche Bank

$16.66

0.92 (5.85%)

06:56
12/06/16
12/06
06:56
12/06/16
06:56
Periodicals
Barclays energy trading exit a worry for cash-strapped producers, Reuters says »

Barclays' (BCS) exit…

BCS

Barclays

$10.97

0.27 (2.52%)

DB

Deutsche Bank

$16.66

0.92 (5.85%)

RBS

RBS

$5.03

0.12 (2.44%)

GS

Goldman Sachs

$228.55

5.19 (2.32%)

JPM

JPMorgan

$83.26

1.66 (2.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

  • 10

    Jan

  • 13

    Jan

  • 28

    Feb

  • 14

    Jul

  • 12

    Oct

RCII

Rent-A-Center

$11.91

0.38 (3.30%)

06:55
12/06/16
12/06
06:55
12/06/16
06:55
Downgrade
Rent-A-Center rating change  »

Rent-A-Center downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LSCC

Lattice Semiconductor

$7.10

0.16 (2.31%)

06:54
12/06/16
12/06
06:54
12/06/16
06:54
Periodicals
U.S. politicians request block of $1.3B Chinese buyout of Lattice, Reuters says »

More than 20 U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RES

RPC, Inc.

$21.63

0.31 (1.45%)

06:53
12/06/16
12/06
06:53
12/06/16
06:53
Downgrade
RPC, Inc. rating change  »

RPC, Inc. downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.